JP2022519935A5 - - Google Patents
Info
- Publication number
- JP2022519935A5 JP2022519935A5 JP2021557909A JP2021557909A JP2022519935A5 JP 2022519935 A5 JP2022519935 A5 JP 2022519935A5 JP 2021557909 A JP2021557909 A JP 2021557909A JP 2021557909 A JP2021557909 A JP 2021557909A JP 2022519935 A5 JP2022519935 A5 JP 2022519935A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cytokine
- manipulated
- population
- car
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962826856P | 2019-03-29 | 2019-03-29 | |
| US62/826,856 | 2019-03-29 | ||
| PCT/US2020/024671 WO2020205359A1 (en) | 2019-03-29 | 2020-03-25 | Methods for production of car-nk cells and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519935A JP2022519935A (ja) | 2022-03-25 |
| JP2022519935A5 true JP2022519935A5 (enExample) | 2023-04-03 |
Family
ID=72667448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557909A Pending JP2022519935A (ja) | 2019-03-29 | 2020-03-25 | Ｃａｒ－ｎｋ細胞の作製方法およびその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220325245A1 (enExample) |
| EP (1) | EP3947647A4 (enExample) |
| JP (1) | JP2022519935A (enExample) |
| KR (1) | KR20220004992A (enExample) |
| CN (1) | CN113811604A (enExample) |
| AR (1) | AR118510A1 (enExample) |
| AU (1) | AU2020254420A1 (enExample) |
| BR (1) | BR112021019411A2 (enExample) |
| CA (1) | CA3135407A1 (enExample) |
| CO (1) | CO2021012719A2 (enExample) |
| MX (1) | MX2021011816A (enExample) |
| TW (1) | TW202104252A (enExample) |
| WO (1) | WO2020205359A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101520534B1 (ko) | 2012-05-07 | 2015-05-21 | 고려대학교 산학협력단 | 말초혈액단핵구 유래 자연 살해세포의 유도 및 증식 방법 |
| CN115710576A (zh) | 2018-02-01 | 2023-02-24 | Nkmax有限公司 | 产生天然杀伤细胞的方法和用于治疗癌症的组合物 |
| WO2019165121A1 (en) | 2018-02-21 | 2019-08-29 | Board Of Regents, The University Of Texas System | Methods for activation and expansion of natural killer cells and uses therof |
| SG11202010763VA (en) * | 2018-05-03 | 2020-11-27 | Univ Texas | Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade |
| JP7773789B2 (ja) | 2020-03-28 | 2025-11-20 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 癌の治療のための細胞免疫療法 |
| GB202005216D0 (en) * | 2020-04-08 | 2020-05-20 | Autolus Ltd | Cell |
| AU2022218710A1 (en) * | 2021-02-09 | 2023-08-10 | Takeda Pharmaceutical Company Limited | Methods and compositions for freezing and thawing mammalian cells |
| IL310307A (en) * | 2021-07-23 | 2024-03-01 | Univ Texas | Cd3-expressing natural killer cells with enhanced function for adoptive immunotherapy |
| CN116262793A (zh) * | 2021-12-13 | 2023-06-16 | 上海恒润达生生物科技股份有限公司 | 膜整合型融合蛋白、含有其的细胞及用途 |
| WO2023164455A2 (en) * | 2022-02-23 | 2023-08-31 | Aloe Therapeutics Inc | Compositions and methods to modulate the immune system |
| CN115896016B (zh) * | 2022-09-07 | 2023-09-12 | 普华赛尔生物医疗科技有限公司 | 培养组合物及其在培养免疫细胞中的应用 |
| WO2024058589A1 (ko) * | 2022-09-16 | 2024-03-21 | 한국과학기술연구원 | 유전자 가위 넉-인을 이용하여 제조한 키메릭 항원 수용체 세포 및 이의 용도 |
| EP4602152A1 (en) * | 2022-10-10 | 2025-08-20 | Kite Pharma, Inc. | New large scale car-t immune cell manufacturing method utilizing lentiviral vector transfection |
| CN116168765B (zh) * | 2023-04-25 | 2023-08-18 | 山东大学 | 基于改进strobemer的基因序列生成方法及系统 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025006799A1 (en) * | 2023-06-27 | 2025-01-02 | Capstan Therapeutics, Inc. | Extracorporeal and ex vivo engineering of select cell populations from peripheral blood |
| CN116769722B (zh) * | 2023-07-04 | 2024-07-16 | 杭州荣谷生物科技有限公司 | 功能增强型car-nk细胞、其制备方法及其在免疫疗法中的应用 |
| EP4784165A1 (en) * | 2023-09-25 | 2026-08-05 | Legend Biotech USA Inc. | Modified immune cells and calcineurin inhibitors and uses thereof |
| WO2025169136A1 (en) * | 2024-02-09 | 2025-08-14 | Takeda Pharmaceutical Company Limited | Dosing regimen for cd19 car nk cells in treating cancer |
| US12655391B2 (en) * | 2024-02-28 | 2026-06-16 | Gene Solutions Joint Stock Company | Modified K562 feeder cell line expressing factors that enhance the activation and proliferation of natural killer cells and a method for its production |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015339447B2 (en) * | 2014-10-27 | 2021-08-12 | University Of Central Florida Research Foundation, Inc. | Methods and compositions for natural killer cells |
| EP3138905A1 (en) * | 2015-09-04 | 2017-03-08 | Miltenyi Biotec GmbH | Method for natural killer cell expansion |
| CN107868791B (zh) * | 2016-09-26 | 2021-11-23 | 阿思科力(苏州)生物科技有限公司 | 一种加强型Slit2 CAR-T和CAR-NK细胞制备方法和应用 |
| JP2020517259A (ja) * | 2017-04-19 | 2020-06-18 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 操作された抗原受容体を発現する免疫細胞 |
| SG11202008008UA (en) * | 2018-02-21 | 2020-09-29 | Univ Texas | Universal antigen presenting cells and uses thereof |
| SG11202010763VA (en) * | 2018-05-03 | 2020-11-27 | Univ Texas | Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade |
| EP3790958A1 (en) * | 2018-05-08 | 2021-03-17 | Life Technologies Corporation | Compositions and methods for culturing and expanding cells |
-
2020
- 2020-03-25 EP EP20782753.6A patent/EP3947647A4/en active Pending
- 2020-03-25 CN CN202080032042.7A patent/CN113811604A/zh active Pending
- 2020-03-25 BR BR112021019411A patent/BR112021019411A2/pt not_active Application Discontinuation
- 2020-03-25 AU AU2020254420A patent/AU2020254420A1/en active Pending
- 2020-03-25 WO PCT/US2020/024671 patent/WO2020205359A1/en not_active Ceased
- 2020-03-25 KR KR1020217035535A patent/KR20220004992A/ko active Pending
- 2020-03-25 CA CA3135407A patent/CA3135407A1/en active Pending
- 2020-03-25 MX MX2021011816A patent/MX2021011816A/es unknown
- 2020-03-25 JP JP2021557909A patent/JP2022519935A/ja active Pending
- 2020-03-25 US US17/593,085 patent/US20220325245A1/en active Pending
- 2020-03-27 TW TW109110593A patent/TW202104252A/zh unknown
- 2020-03-27 AR ARP200100857A patent/AR118510A1/es unknown
-
2021
- 2021-09-27 CO CONC2021/0012719A patent/CO2021012719A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ghasemi et al. | Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy | |
| US20220251509A1 (en) | Platform for activation and expansion of virus-specific t-cells | |
| JP2021522798A5 (enExample) | ||
| US10500265B2 (en) | Generation of HPV-specific T-cells | |
| Zhou et al. | Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells | |
| JP2022513665A5 (enExample) | ||
| JP2019523001A5 (enExample) | ||
| JP6543375B1 (ja) | ケモカインレセプターと細胞接着分子を発現するｃｄ３陰性細胞の集団、およびその利用 | |
| JPH10504284A (ja) | 抗原パルス化樹状細胞によるｉｎ ｖｉｖｏ Ｔ細胞活性化法 | |
| US20210147803A1 (en) | Method for producing natural killer cells | |
| JP2022511735A5 (enExample) | ||
| Margolin et al. | Cellular immunotherapy and autologous transplantation for hematologic malignancy | |
| JP3619853B2 (ja) | ナチュラルキラー細胞の増殖方法 | |
| WO1995006409A1 (en) | Genetically modified human hematopoietic stem cells and their progeny | |
| JP2024509095A5 (enExample) | ||
| JPWO2007105797A1 (ja) | 新規なヒトｔ細胞集団 | |
| WO2025255886A1 (zh) | 一种诱导性nk细胞及其制备方法和应用 | |
| CN113613723A (zh) | 包含nk细胞的细胞群体的制造方法 | |
| WO2019217512A1 (en) | Compositions and methods for culturing and expanding cells | |
| CN114402065A (zh) | 低密度细胞培养 | |
| Sánchez et al. | Beyond CAR-T cells: Natural killer cells immunotherapy | |
| KR20220036287A (ko) | 고순도 및 고효율의 자연살해세포 제조방법 및 이의 용도 | |
| WO2026011501A1 (zh) | 一种靶向cd19的car-nk细胞及其制备方法和应用 | |
| CN102802686A (zh) | 骨髓胞外基质提取物及其治疗用途 | |
| JPWO2021100585A5 (enExample) |